Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Lippman

Showing results (181-190 of 240) with videos related to

Pageof 24
Sort By:
Cancer Research|June 5, 2001
Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesisX C Xu, W Y Wong, L Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancerF V Fossella, J S Lee, W K Murphy, et al.
Journal of the National Cancer Institute|February 14, 1998
Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tractM R Spitz, S M Lippman, H Jiang, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancerN Voravud, S M Lippman, R S Weber, et al.
Investigational New Drugs|April 1, 1988
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trialS M Lippman, J F Kessler, M Al-Sarraf, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Retinoic acid and interferon combination studies in human cancerS M Lippman, B S Glisson, J J Kavanagh, et al.
The New England Journal of Medicine|January 7, 1993
Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesisS M Lippman, J G Batsakis, B B Toth, et al.
Leukemia|October 1, 1994
Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumorsE A Eisenhauer, S M Lippman, J J Kavanagh, et al.
Leukemia|January 1, 1994
Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumorsE A Eisenhauer, S M Lippman, J J Kavanagh, et al.
Journal of the National Cancer Institute|March 17, 1993
13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervixS M Lippman, J J Kavanagh, M Paredes-Espinoza, et al.
Pageof 24

Showing results (181-190 of 240) with videos related to

Sort By:
Pageof 24
Cancer Research|June 5, 2001
Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesisX C Xu, W Y Wong, L Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancerF V Fossella, J S Lee, W K Murphy, et al.
Journal of the National Cancer Institute|February 14, 1998
Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tractM R Spitz, S M Lippman, H Jiang, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancerN Voravud, S M Lippman, R S Weber, et al.
Investigational New Drugs|April 1, 1988
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trialS M Lippman, J F Kessler, M Al-Sarraf, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Retinoic acid and interferon combination studies in human cancerS M Lippman, B S Glisson, J J Kavanagh, et al.
The New England Journal of Medicine|January 7, 1993
Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesisS M Lippman, J G Batsakis, B B Toth, et al.
Leukemia|October 1, 1994
Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumorsE A Eisenhauer, S M Lippman, J J Kavanagh, et al.
Leukemia|January 1, 1994
Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumorsE A Eisenhauer, S M Lippman, J J Kavanagh, et al.
Journal of the National Cancer Institute|March 17, 1993
13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervixS M Lippman, J J Kavanagh, M Paredes-Espinoza, et al.
Pageof 24